Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Medical College of Wisconsin
Medical College of Wisconsin
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Novo Nordisk A/S
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
BerGenBio ASA
Eastern Cooperative Oncology Group
University of Washington
Children's Oncology Group
University of Washington
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Duke University
Pfizer
Baylor College of Medicine
Mayo Clinic
M.D. Anderson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Baylor College of Medicine
Baylor College of Medicine
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Hoffmann-La Roche
M.D. Anderson Cancer Center
Washington University School of Medicine
University of Chicago
Novartis
Case Comprehensive Cancer Center
Baylor Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center